Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion type Assertion NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_head.
- NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion description "[The demonstration of cross-lineage rearrangement of both Ig and TCR genes lends support to evidence from G6PD alloenzyme studies that the target of transformation in aCML is an early stem cell not yet irreversibly committed to myeloid differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_provenance.
- NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion evidence source_evidence_literature NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_provenance.
- NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion SIO_000772 1826535 NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_provenance.
- NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion wasDerivedFrom befree-2016 NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_provenance.
- NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_assertion wasGeneratedBy ECO_0000203 NP654805.RASm21N4i-s-yS1mF_cA7DTfHjdWexxaMJfSVzsdPkccs130_provenance.